D'Argento E - Search Results

1

State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.

Inno A, Di Noia V, D'Argento E, Modena A, Gori S. Inno A, et al. Transl Lung Cancer Res. 2016 Dec;5(6):599-609. doi: 10.21037/tlcr.2016.11.01. Transl Lung Cancer Res. 2016. PMID: 28149755 Free PMC article. Review.

2

Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy.

Mannino M, Sollena P, Di Stefani A, Rossi E, D'Argento E, Schinzari G, Tortora G, Peris K. Mannino M, et al. Among authors: d argento e. Dermatology. 2024;240(4):523-530. doi: 10.1159/000536332. Epub 2024 Apr 17. Dermatology. 2024. PMID: 38631324

3

Anastrozole-related acute hepatitis with autoimmune features: a case report.

Inno A, Basso M, Vecchio FM, Marsico VA, Cerchiaro E, D'Argento E, Bagalà C, Barone C. Inno A, et al. BMC Gastroenterol. 2011 Mar 31;11:32. doi: 10.1186/1471-230X-11-32. BMC Gastroenterol. 2011. PMID: 21453541 Free PMC article.

4

Are TKIs favourable for the elderly with non-small-cell lung cancer?

Rossi S, D'Argento E, Schinzari G, Dadduzio V, Di Noia V, Cassano A, Barone C. Rossi S, et al. Oncotarget. 2016 Jul 26;7(30):46871-46877. doi: 10.18632/oncotarget.9389. Oncotarget. 2016. PMID: 27206674 Free PMC article.

5

From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer?

D'Argento E, Rossi S, Schinzari G, Strippoli A, Basso M, Cassano A, Barone C. D'Argento E, et al. Curr Treat Options Oncol. 2016 Dec;17(12):59. doi: 10.1007/s11864-016-0437-x. Curr Treat Options Oncol. 2016. PMID: 27766545 Review.

6

DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.

Di Noia V, Basso M, Marsico V, Cerchiaro E, Rossi S, D'Argento E, Strippoli A, Schinzari G, Iezzi R, Cassano A, Barone C. Di Noia V, et al. Future Oncol. 2019 Jul;15(20):2349-2360. doi: 10.2217/fon-2017-0025. Epub 2017 Apr 25. Future Oncol. 2019. PMID: 28440086 Clinical Trial.

7

Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?

Rossi S, Di Noia V, Tonetti L, Strippoli A, Basso M, Schinzari G, Cassano A, Leone A, Barone C, D'Argento E. Rossi S, et al. Future Oncol. 2018 Apr;14(10):919-926. doi: 10.2217/fon-2017-0499. Epub 2018 Mar 12. Future Oncol. 2018. PMID: 29528255

8

Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis.

Inno A, Di Noia V, Martini M, D'Argento E, Di Salvatore M, Arena V, Schinzari G, Orlandi A, Larocca LM, Cassano A, Barone C. Inno A, et al. Pathol Oncol Res. 2019 Apr;25(2):513-520. doi: 10.1007/s12253-018-0404-x. Epub 2018 Mar 20. Pathol Oncol Res. 2019. PMID: 29557085 Free article.

9

The interference between oxaliplatin & anti-EGFR therapies: a different hypothesis to explain the 'unexplainable'.

Basso M, Dadduzio V, Rossi S, D'Argento E, Strippoli A, Di Salvatore M, Orlandi A, Zurlo V, Di Noia V, Barone C. Basso M, et al. Per Med. 2018 Jul 1;15(4):319-327. doi: 10.2217/pme-2017-0082. Epub 2018 Jun 21. Per Med. 2018. PMID: 29927360

10

Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies.

di Noia V, D'Argento E, Pilotto S, Grizzi G, Caccese M, Iacovelli R, Tortora G, Bria E. di Noia V, et al. Expert Opin Biol Ther. 2018 Sep;18(9):937-945. doi: 10.1080/14712598.2018.1508445. Epub 2018 Aug 9. Expert Opin Biol Ther. 2018. PMID: 30075697 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters